Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2025-12-24 @ 3:56 PM
NCT ID: NCT00709592
Eligibility Criteria: Inclusion Criteria: * Patients with hematological malignancies for which allogeneic stem cell transplantation indicated including non-Hodgkin lymphoma (NHL), multiple myeloma (MM), acute myeloid leukemia (AML), Hodgkin lymphoma (HD), chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), and myelodysplastic syndrome (MDS) * Patients with HLA compatible related or unrelated stem cell donor, willing and able to serve as an allogenic HSC donor. Unrelated donors have to be matched at HLA-A, B, C and DRB1 loci. A single locus mismatch will be tolerated in the event a more closely matched donor is not available. * Patients age \>/=40 to \</=70 with an ECOG performance status \< 2 * Patients between 18 and 40 years of age will be eligible only if they have co-morbidities precluding conventional allogeneic transplantation with full intensity myeloablative conditioning * Adequate cardiac, pulmonary, renal and hepatic function for transplant * Negative serology for HIV * Negative serum pregnancy test * Patients who have received therapeutic radiation to a localized field will be eligible, provided critical structure tolerance doses have not been exceeded * Patients who have had prior myeloablative autologous transplant will be eligible Exclusion Criteria: * Evidence of uncontrolled viral, fungal, bacterial infection * Evidence of active meningeal or CNS disease * Prior therapy with rabbit ATG, prior treatment with equine ATG is allowed if more than 3 months ago * Breast feeding mothers are excluded
Healthy Volunteers: False
Sex: ALL
Minimum Age: 40 Years
Maximum Age: 70 Years
Study: NCT00709592
Study Brief:
Protocol Section: NCT00709592